Thrilled to announce the launch of Codon Communications today! A new #PRagency delivering scientifically sound content & a portfolio of reputation-building, audience-engaging #PR for the #lifescience industry. Follow us for industry #news.
#messengersinscience#biotech#science
Protecting what cannot be replaced: designing resilient storage for advanced therapies🧊
✏️By Philip Bradley and Matthew Ball at @astoriom_pharma
Read here: https://t.co/gAs3gTd3qd
As the year comes to a close, we're looking ahead to 2026 and wondering what we can expect. We asked researchers and industry insiders to share their predictions on precision medicine, animal models, companion diagnostics, and more.
Read here: https://t.co/6oX9uUCixD
AI is transforming how scientists mine biology for therapeutics, allowing researchers to dive deeper into both human and ancient biology to look for novel therapeutic molecules.
We spoke with @delafuentelab – Presidential Associate Professor at @Penn – at @ELRIG_SCIENCE's Drug Discovery 2025 to learn how he has expanded the search for novel antibiotics with advanced AI models >>> https://t.co/QgDywlCylz
At @ELRIG_SCIENCE's Drug Discovery 2025, we learned about how Yanyan Zhao and her colleagues at the University of Cambridge have approached the preclinical development of a PET imaging tracer for earlier Alzheimer’s disease diagnosis >>> https://t.co/QF5XGUKoYS
In this interview from @ELRIG_SCIENCE's #DD25, Namshik Han – Professor at Yonsei University and leader of the AI discovery group in the Milner Therapeutics Institute @Cambridge_Uni – explains quantum algorithms with a London Tube analogy, how they can be applied to benefit drug discovery and his advice for researchers wanting to launch their own startups >>> https://t.co/1bT5f68fm2